5-(Diaminomethylideneamino)-2-[[21-[3-(diaminomethylideneamino)propyl]-12-(2-methylpropyl)-10,13,16,19,22,25-hexaoxo-9-[(5-oxopyrrolidine-2-carbonyl)amino]-8,15-di(propan-2-yl)-2,11,14,17,20,23,26,30,32-nonazapentacyclo[16.14.2.13,7.129,32.04,33]hexatriaconta-1(33),3,5,7(36),29(35),30-hexaene-27-carbonyl]amino]pentanoic acid
Internal ID | 6b2699cf-07dc-4d2f-b29b-cc47b3c98633 |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
IUPAC Name | 5-(diaminomethylideneamino)-2-[[21-[3-(diaminomethylideneamino)propyl]-12-(2-methylpropyl)-10,13,16,19,22,25-hexaoxo-9-[(5-oxopyrrolidine-2-carbonyl)amino]-8,15-di(propan-2-yl)-2,11,14,17,20,23,26,30,32-nonazapentacyclo[16.14.2.13,7.129,32.04,33]hexatriaconta-1(33),3,5,7(36),29(35),30-hexaene-27-carbonyl]amino]pentanoic acid |
SMILES (Canonical) | CC(C)CC1C(=O)NC(C(=O)NC2CC3=C(NC4=C3C=CC(=C4)C(C(C(=O)N1)NC(=O)C5CCC(=O)N5)C(C)C)N6C=C(CC(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)N=C6)C(C)C |
SMILES (Isomeric) | CC(C)CC1C(=O)NC(C(=O)NC2CC3=C(NC4=C3C=CC(=C4)C(C(C(=O)N1)NC(=O)C5CCC(=O)N5)C(C)C)N6C=C(CC(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)N=C6)C(C)C |
InChI | InChI=1S/C53H78N18O11/c1-24(2)17-35-48(78)69-41(26(5)6)49(79)68-37-20-30-29-12-11-27(40(25(3)4)42(50(80)67-35)70-45(75)32-13-14-38(72)62-32)18-34(29)64-43(30)71-22-28(61-23-71)19-36(46(76)66-33(51(81)82)10-8-16-59-53(56)57)63-39(73)21-60-44(74)31(65-47(37)77)9-7-15-58-52(54)55/h11-12,18,22-26,31-33,35-37,40-42,64H,7-10,13-17,19-21H2,1-6H3,(H,60,74)(H,62,72)(H,63,73)(H,65,77)(H,66,76)(H,67,80)(H,68,79)(H,69,78)(H,70,75)(H,81,82)(H4,54,55,58)(H4,56,57,59) |
InChI Key | VRPGLWBFMCZAOM-UHFFFAOYSA-N |
Popularity | 0 references in papers |
Molecular Formula | C53H78N18O11 |
Molecular Weight | 1143.30 g/mol |
Exact Mass | 1142.60974538 g/mol |
Topological Polar Surface Area (TPSA) | 462.00 Ų |
XlogP | -1.00 |
Atomic LogP (AlogP) | -3.11 |
H-Bond Acceptor | 14 |
H-Bond Donor | 15 |
Rotatable Bonds | 17 |
There are no found synonyms. |
![2D Structure of 5-(Diaminomethylideneamino)-2-[[21-[3-(diaminomethylideneamino)propyl]-12-(2-methylpropyl)-10,13,16,19,22,25-hexaoxo-9-[(5-oxopyrrolidine-2-carbonyl)amino]-8,15-di(propan-2-yl)-2,11,14,17,20,23,26,30,32-nonazapentacyclo[16.14.2.13,7.129,32.04,33]hexatriaconta-1(33),3,5,7(36),29(35),30-hexaene-27-carbonyl]amino]pentanoic acid 2D Structure of 5-(Diaminomethylideneamino)-2-[[21-[3-(diaminomethylideneamino)propyl]-12-(2-methylpropyl)-10,13,16,19,22,25-hexaoxo-9-[(5-oxopyrrolidine-2-carbonyl)amino]-8,15-di(propan-2-yl)-2,11,14,17,20,23,26,30,32-nonazapentacyclo[16.14.2.13,7.129,32.04,33]hexatriaconta-1(33),3,5,7(36),29(35),30-hexaene-27-carbonyl]amino]pentanoic acid](https://plantaedb.com/storage/docs/compounds/2023/11/4a47d430-8629-11ee-8cc3-131d3a2716bb.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9061 | 90.61% |
Caco-2 | - | 0.8625 | 86.25% |
Blood Brain Barrier | - | 0.6250 | 62.50% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Mitochondria | 0.4055 | 40.55% |
OATP2B1 inhibitior | - | 0.8588 | 85.88% |
OATP1B1 inhibitior | + | 0.8154 | 81.54% |
OATP1B3 inhibitior | + | 0.9398 | 93.98% |
MATE1 inhibitior | - | 0.7209 | 72.09% |
OCT2 inhibitior | - | 0.6750 | 67.50% |
BSEP inhibitior | + | 0.9672 | 96.72% |
P-glycoprotein inhibitior | + | 0.7454 | 74.54% |
P-glycoprotein substrate | + | 0.8755 | 87.55% |
CYP3A4 substrate | + | 0.7441 | 74.41% |
CYP2C9 substrate | - | 0.5968 | 59.68% |
CYP2D6 substrate | - | 0.8534 | 85.34% |
CYP3A4 inhibition | - | 0.9549 | 95.49% |
CYP2C9 inhibition | - | 0.8277 | 82.77% |
CYP2C19 inhibition | - | 0.7909 | 79.09% |
CYP2D6 inhibition | - | 0.9033 | 90.33% |
CYP1A2 inhibition | - | 0.8357 | 83.57% |
CYP2C8 inhibition | + | 0.8314 | 83.14% |
CYP inhibitory promiscuity | - | 0.9592 | 95.92% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.8800 | 88.00% |
Carcinogenicity (trinary) | Non-required | 0.6145 | 61.45% |
Eye corrosion | - | 0.9859 | 98.59% |
Eye irritation | - | 0.8979 | 89.79% |
Skin irritation | - | 0.7706 | 77.06% |
Skin corrosion | - | 0.9307 | 93.07% |
Ames mutagenesis | - | 0.6500 | 65.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6757 | 67.57% |
Micronuclear | + | 0.8700 | 87.00% |
Hepatotoxicity | + | 0.5928 | 59.28% |
skin sensitisation | - | 0.8505 | 85.05% |
Respiratory toxicity | + | 0.8111 | 81.11% |
Reproductive toxicity | + | 0.9333 | 93.33% |
Mitochondrial toxicity | + | 0.9000 | 90.00% |
Nephrotoxicity | - | 0.8104 | 81.04% |
Acute Oral Toxicity (c) | III | 0.5582 | 55.82% |
Estrogen receptor binding | + | 0.7241 | 72.41% |
Androgen receptor binding | + | 0.7299 | 72.99% |
Thyroid receptor binding | + | 0.6471 | 64.71% |
Glucocorticoid receptor binding | + | 0.6191 | 61.91% |
Aromatase binding | + | 0.7162 | 71.62% |
PPAR gamma | + | 0.7576 | 75.76% |
Honey bee toxicity | - | 0.6898 | 68.98% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
Fish aquatic toxicity | + | 0.8034 | 80.34% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL4040 | P28482 | MAP kinase ERK2 | 100.00% | 83.82% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.87% | 96.09% |
CHEMBL2581 | P07339 | Cathepsin D | 99.64% | 98.95% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.64% | 94.45% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.28% | 91.11% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 97.08% | 93.10% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.08% | 90.08% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 96.82% | 88.56% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.39% | 97.09% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.11% | 99.17% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.52% | 90.71% |
CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 95.47% | 90.24% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.62% | 93.56% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 93.88% | 85.14% |
CHEMBL2535 | P11166 | Glucose transporter | 93.83% | 98.75% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.08% | 95.89% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 92.94% | 94.75% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 92.11% | 97.23% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.02% | 96.00% |
CHEMBL220 | P22303 | Acetylcholinesterase | 90.99% | 94.45% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 90.89% | 98.59% |
CHEMBL3384 | Q16512 | Protein kinase N1 | 90.18% | 80.71% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.10% | 95.56% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 90.00% | 96.47% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.50% | 97.64% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 87.76% | 82.86% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.70% | 100.00% |
CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 86.05% | 87.16% |
CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 85.70% | 99.09% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.45% | 89.00% |
CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 85.12% | 83.10% |
CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 84.20% | 91.79% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 84.18% | 86.33% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 84.03% | 98.33% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 84.00% | 99.23% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 83.67% | 93.99% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 83.46% | 95.89% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.19% | 93.00% |
CHEMBL1781 | P11387 | DNA topoisomerase I | 82.66% | 97.00% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 82.06% | 95.58% |
CHEMBL5028 | O14672 | ADAM10 | 82.01% | 97.50% |
CHEMBL5747 | Q92793 | CREB-binding protein | 81.66% | 95.12% |
CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 81.32% | 88.33% |
CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 80.67% | 85.83% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 80.61% | 100.00% |
CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 80.58% | 89.67% |
CHEMBL3524 | P56524 | Histone deacetylase 4 | 80.46% | 92.97% |
CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 80.22% | 100.00% |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 80.21% | 95.56% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Celosia argentea |
PubChem | 85118794 |
LOTUS | LTS0266782 |
wikiData | Q105291900 |